mesalamine has been researched along with Liver Cirrhosis in 4 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Liver fibrosis is a major health issue leading to high morbidity and mortality." | 1.48 | Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in rats. ( Abd El-Rahman, SS; Abdel-Rahman, RF; Afifi, N; Fayed, HM; Ramadan, A; Yassin, NZ, 2018) |
| "We present a case of ulcerative colitis in a pediatric liver transplant recipient." | 1.35 | De novo inflammatory bowel disease after pediatric orthotopic liver transplant: a case report. ( Bahador, A; Dehghani, SM; Eshraghian, A; Geramizadeh, B; Kakaei, F; Malek-Hosseini, SA, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramadan, A | 1 |
| Afifi, N | 1 |
| Yassin, NZ | 1 |
| Abdel-Rahman, RF | 1 |
| Abd El-Rahman, SS | 1 |
| Fayed, HM | 1 |
| Dehghani, SM | 1 |
| Eshraghian, A | 1 |
| Bahador, A | 1 |
| Kakaei, F | 1 |
| Geramizadeh, B | 1 |
| Malek-Hosseini, SA | 1 |
| Leal-Valdivieso, C | 1 |
| Naves, JE | 1 |
| Mañosa, M | 1 |
| Zabana, Y | 1 |
| Cabré, E | 1 |
| Domènech, E | 1 |
4 other studies available for mesalamine and Liver Cirrhosis
| Article | Year |
|---|---|
Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in rats.
Topics: Actins; Animals; Biomarkers; Caspase 3; Immunohistochemistry; Liver; Liver Cirrhosis; Liver Function | 2018 |
De novo inflammatory bowel disease after pediatric orthotopic liver transplant: a case report.
Topics: Adolescent; Anti-Inflammatory Agents; Biopsy; Chronic Disease; Colitis, Ulcerative; Colon; Colonosco | 2009 |
[Portal hypertension in patients with inflammatory bowel disease].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Ascites; Crohn Disease; Female; | 2010 |
[Gastroenterology and hepatology. Using established therapies].
Topics: Anti-Inflammatory Agents; Clinical Trials as Topic; Colitis, Ulcerative; Combined Modality Therapy; | 2010 |